CN112294905A - 一种治疗病窦综合症失眠的药物组合物及其应用 - Google Patents

一种治疗病窦综合症失眠的药物组合物及其应用 Download PDF

Info

Publication number
CN112294905A
CN112294905A CN202011274101.XA CN202011274101A CN112294905A CN 112294905 A CN112294905 A CN 112294905A CN 202011274101 A CN202011274101 A CN 202011274101A CN 112294905 A CN112294905 A CN 112294905A
Authority
CN
China
Prior art keywords
parts
traditional chinese
insomnia
treating
sick sinus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011274101.XA
Other languages
English (en)
Inventor
李彩华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIMEN PEOPLE S HOSPITAL
Original Assignee
SHIMEN PEOPLE S HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIMEN PEOPLE S HOSPITAL filed Critical SHIMEN PEOPLE S HOSPITAL
Priority to CN202011274101.XA priority Critical patent/CN112294905A/zh
Publication of CN112294905A publication Critical patent/CN112294905A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/69Polygalaceae (Milkwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及中药技术领域,尤其涉及一种治疗病窦综合症失眠的中药组合物,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:柴胡6‑12份,白芍8‑15份,枳壳5‑10份,川芎5‑10份,延胡索6‑15份,郁金3‑10份,白芨4‑10份,贝母4‑10份,陈皮2‑10份,党参5‑10份,茯苓5‑10份,海螵蛸5‑10份,藕节炭8‑15份,木蝴蝶3‑10份,甘草1‑5份,处方组成独特,疏肝理气,健脾和胃,收敛止血,具有良好的治疗效果。

Description

一种治疗病窦综合症失眠的药物组合物及其应用
技术领域
本发明涉及中药技术领域,尤其涉及一种治疗病窦综合症失眠的药物组合物及其应用。
背景技术
病态窦房结综合征简称病窦综合征,又称窦房结功能不全,是由窦房结及其邻近组织病变引起窦房结起搏功能和(或)窦房传导功能障碍,从而产生多种心律失常和临床症状的一组综合征。病窦综合征时,除窦房结的病理改变外,还可合并心房、房室交界处及心脏全传导系统的病理改变。其中,大多数患者在40岁以上出现症状,60~70岁最多见。
病窦综合征常导致失眠不寐、气虚血瘀等,严重影响生活。
发明内容
本发明的目的在于提供一种治疗病窦综合症失眠的药物组合物及其应用。
为了解决上述技术问题,本发明一种治疗病窦综合症失眠的中药组合物,同时提供其制备方法。制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:
麻黄3-6份、附片5-10份、细辛1-5份、丹参5-30份、三七8-30份、桂枝5-10份、红参60-90份、炙黄芪10-30份、大枣3-10份、炙甘草3-10份、远志3-8份、茯神8-20份、香附子5-10份、酸枣仁5-15份。
在其中一个实施例中,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:麻黄3份、附片10份、细辛5份、丹参15份、三七10份、桂枝10份、红参60份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20 份、香附子10份、酸枣仁15份。
在其中一个实施例中,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:麻黄6份、附片10份、细辛5份、丹参30份、三七30份、桂枝 10份、红参90份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20 份、香附子10份、酸枣仁15份。
其中,所述的药物组合物在制备下述任一种药物中的应用:
1)治疗病窦综合症失眠的的药物;
2)治疗窦性心动过缓失眠的的药物;
3)治疗房室传导阻滞失眠的的药物。
本发明有益效果:本发明处方组成独特,主治素体阳虚,麻黄发汗解表,附子温经助阳,以鼓邪外出,良药相合,温散寒邪而恢复阳气,细辛外解太阳之表,内散少阴之寒,既能珠麻黄发汗解表,又助附子温经散寒,结合丹参、三七等,补散兼施,共奏助阳解表之功,在治疗病窦综合症失眠方面具有良好的治疗效果。
具体实施方式
下面结合实施例对本发明作进一步详细描述。
实施例一
一种治疗病窦综合症失眠的药物组合物,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:
麻黄3份、附片5份、细辛1份、丹参5份、三七8份、桂枝5份、红参60 份、炙黄芪10份、大枣3份、炙甘草3份、远志3份、茯神8份、香附子5份、酸枣仁5份。
使用时,取上述组份常规煎水形成汤剂,每日分三次口服。
实施例二
一种治疗病窦综合症失眠的药物组合物,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:
麻黄4份、附片6份、细辛4份、丹参20份、三七20份、桂枝8份、红参 80份、炙黄芪20份、大枣6份、炙甘草5份、远志5份、茯神10份、香附子8 份、酸枣仁8份。
使用时,取上述组份常规煎水形成汤剂,每日分三次口服。
实施例三
一种治疗病窦综合症失眠的药物组合物,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:
麻黄3份、附片10份、细辛5份、丹参15份、三七10份、桂枝10份、红参60份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20份、香附子10份、酸枣仁15份。
使用时,取上述组份常规煎水形成汤剂,每日分三次口服。
实施例四
一种治疗病窦综合症失眠的药物组合物,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:
麻黄6份、附片10份、细辛5份、丹参30份、三七30份、桂枝10份、红参90份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20份、香附子10份、酸枣仁15份。
本实施例针对气虚血瘀明显者,重用三七、丹参。使用时,取上述组份常规煎水形成汤剂,每日分三次口服。
为表明本发明药物的疗效,进行了如下临床对比试验。
临床对象来源于2019年8月至2020年9月,在我院的住院患者,选取其中符合消化性溃疡出血纳入标准的患者共140例。
分组方法:选取符合纳入标准的患者随机分为治疗组以及对照组。随机对照组70例(西医常规治疗),治疗组70例(西医常规治疗+本实施例所制黄麻附子细辛汤)。
治疗方法
对照组:运用基础药物(β-受体阻滞剂、维拉帕米、洋地黄类制剂等以及其他抗心律失常药物)进行抑制。
治疗组(西医常规治疗+黄麻附子细辛汤):在西医常规治疗的基础上,给予本实施例所制黄麻附子细辛汤一剂,煎水200ml,每日分三次口服。
观察疗程:2周1个疗程,1个疗程后观察患者临床症状及3个月后复查内镜的镜下表现。
观察指标:
疗效标准:通过失眠症状是否缓解。
2组患者疗效比较见表1。
表1 2组患者疗效比较(140例)
Figure BDA0002778585180000041
Figure BDA0002778585180000051
以上内容仅为本发明的较佳实施例,对于本领域的普通技术人员,依据本发明的思想,在具体实施方式及应用范围上均会有改变之处,本说明书内容不应理解为对本发明的限制。

Claims (4)

1.一种治疗病窦综合症失眠的中药组合物,其特征在于,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:麻黄3-6份、附片5-10份、细辛1-5份、丹参5-30份、三七8-30份、桂枝5-10份、红参60-90份、炙黄芪10-30份、大枣3-10份、炙甘草3-10份、远志3-8份、茯神8-20份、香附子5-10份、酸枣仁5-15份。
2.根据权利要求1所述的一种治疗病窦综合症失眠的中药组合物,其特征在于,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:麻黄3份、附片10份、细辛5份、丹参15份、三七10份、桂枝10份、红参60份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20份、香附子10份、酸枣仁15份。
3.根据权利要求1所述的一种治疗病窦综合症失眠的中药组合物,其特征在于,制成所述中药组合物的活性成分的原料由下述质量份的中药材组成:麻黄6份、附片10份、细辛5份、丹参30份、三七30份、桂枝10份、红参90份、炙黄芪30份、大枣10份、炙甘草10份、远志8份、茯神20份、香附子10份、酸枣仁15份。
4.权利要求1至3任意一项所述的药物组合物在制备下述任一种药物中的应用 :
1)治疗病窦综合症失眠的的药物;
2)治疗窦性心动过缓失眠的的药物;
3)治疗房室传导阻滞失眠的的药物。
CN202011274101.XA 2020-11-15 2020-11-15 一种治疗病窦综合症失眠的药物组合物及其应用 Pending CN112294905A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011274101.XA CN112294905A (zh) 2020-11-15 2020-11-15 一种治疗病窦综合症失眠的药物组合物及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011274101.XA CN112294905A (zh) 2020-11-15 2020-11-15 一种治疗病窦综合症失眠的药物组合物及其应用

Publications (1)

Publication Number Publication Date
CN112294905A true CN112294905A (zh) 2021-02-02

Family

ID=74334508

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011274101.XA Pending CN112294905A (zh) 2020-11-15 2020-11-15 一种治疗病窦综合症失眠的药物组合物及其应用

Country Status (1)

Country Link
CN (1) CN112294905A (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1393249A (zh) * 2001-07-03 2003-01-29 万挺春 一种治疗心肾阳虚型病态窦房结综合征中药饮剂
CN101822729A (zh) * 2009-03-05 2010-09-08 吉林康乃尔药业有限公司 用于治疗缓慢性心律失常病态窦房结综合征的药物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1393249A (zh) * 2001-07-03 2003-01-29 万挺春 一种治疗心肾阳虚型病态窦房结综合征中药饮剂
CN101822729A (zh) * 2009-03-05 2010-09-08 吉林康乃尔药业有限公司 用于治疗缓慢性心律失常病态窦房结综合征的药物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
代敏: "《细说人体话养生》", 31 January 2009, 中国物资出版社 *
任丽霞: "麻黄附子细辛汤加味治疗病态窦房结综合征22例", 《中西医结合心脑血管病杂志》 *
姜明华: "强窦汤治疗病态窦房结综合征的临床电生理观察", 《中医药学刊》 *
李红卫等: "中药治疗心律失常举隅", 《实用中医药杂志》 *
霍根红: "病窦康口服液治疗病态窦房结综合征30例", 《光明中医》 *

Similar Documents

Publication Publication Date Title
WO2008119130A1 (en) Herbal compositions and methods for treating premenstrual syndrome
CN1060350C (zh) 一种治疗妇女产后病的中药
CN102526691A (zh) 一种治疗痛经的外用贴膏
CN103301426A (zh) 通脉利心胶囊
CN101020031A (zh) 一种治疗痤疮的中草药制剂
CN102397351A (zh) 一种治疗失眠的中药组合物
CN101468148B (zh) 一种治疗冠心病及脑动脉硬化的中药组合物及其制备方法
CN102908391B (zh) 一种治疗皮肤病的中药组合物及其制备方法和应用
CN101496892B (zh) 一种治疗心脑血管疾病的口服中成药
CN115282229B (zh) 一种治疗气虚血淤型冠心病的中药组合物及其制备方法
CN101249184B (zh) 一种用于治疗骨质增生的药物及其制备方法
CN112294905A (zh) 一种治疗病窦综合症失眠的药物组合物及其应用
CN101874850A (zh) 一种治疗慢性荨麻疹的药
US10857186B2 (en) Traditional Chinese medicine composition for treating acute stage of cerebral infarction
CN112603985A (zh) 一种治疗心梗的纯中药透皮擦剂及其制备方法
CN107029055B (zh) 用于治疗肝热血瘀所致白血病的中药复方制剂及制备方法
CN110279823B (zh) 一种治疗登革热的中药组合物及其制备方法
CN103446535A (zh) 一种治疗冠心病的苗药
CN108465084A (zh) 一种治疗冠心病的中药
CN112206279B (zh) 一种治疗室性心律失常的中药组合物及其制备方法和应用
CN114306497B (zh) 一种治疗肾虚血瘀型骨质疏松症的中药组合物、制剂与应用
CN116492431B (zh) 一种治疗扁平疣的药物及其制备方法
CN111494501B (zh) 一种强肾通络组合物、药物及其制备方法
CN106729368B (zh) 一种治疗高血压的药物组合物及其制备方法和用途
CN105748816A (zh) 一种治疗输卵管不通的药物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210202

WD01 Invention patent application deemed withdrawn after publication